Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?

97 One recent large randomized trial of 338 patients with inflammatory bowel disease and iron deficiency anaemia (Hb <12 g/dL and TSAT <20%) showed a trend to improved efficacy with oral iron (iron sulfate 200 mg/day) vs. i.v. iron isomaltoside 1000 in terms of the primary efficacy endpoint of change in Hb from baseline to week 8 ( P = 0.09), but patients with known intolerance to oral iron were excluded and i.v. iron dosing may have been inadequate;

also in 53,322 other papers